nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Pilocarpine—glaucoma	0.151	0.236	CbGbCtD
Fosamprenavir—CYP3A4—Brinzolamide—glaucoma	0.118	0.185	CbGbCtD
Fosamprenavir—CYP3A4—Dorzolamide—glaucoma	0.114	0.178	CbGbCtD
Fosamprenavir—CYP3A4—Methazolamide—glaucoma	0.102	0.159	CbGbCtD
Fosamprenavir—CYP3A4—Acetazolamide—glaucoma	0.0813	0.127	CbGbCtD
Fosamprenavir—CYP3A4—Clonidine—glaucoma	0.0735	0.115	CbGbCtD
Fosamprenavir—Immune system disorder—Brinzolamide—glaucoma	0.00118	0.00327	CcSEcCtD
Fosamprenavir—Asthenia—Carteolol—glaucoma	0.00118	0.00326	CcSEcCtD
Fosamprenavir—Body temperature increased—Methazolamide—glaucoma	0.00118	0.00326	CcSEcCtD
Fosamprenavir—Dizziness—Metipranolol—glaucoma	0.00117	0.00325	CcSEcCtD
Fosamprenavir—Asthenia—Diclofenamide—glaucoma	0.00116	0.00321	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00116	0.0032	CcSEcCtD
Fosamprenavir—Hypersensitivity—Levobunolol—glaucoma	0.00114	0.00317	CcSEcCtD
Fosamprenavir—Pruritus—Diclofenamide—glaucoma	0.00114	0.00316	CcSEcCtD
Fosamprenavir—Malnutrition—Brinzolamide—glaucoma	0.00114	0.00315	CcSEcCtD
Fosamprenavir—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.00114	0.00315	CcSEcCtD
Fosamprenavir—Nervous system disorder—Apraclonidine—glaucoma	0.00113	0.00313	CcSEcCtD
Fosamprenavir—Flatulence—Brinzolamide—glaucoma	0.00112	0.0031	CcSEcCtD
Fosamprenavir—Rash—Metipranolol—glaucoma	0.00112	0.0031	CcSEcCtD
Fosamprenavir—Skin disorder—Apraclonidine—glaucoma	0.00112	0.0031	CcSEcCtD
Fosamprenavir—Dermatitis—Metipranolol—glaucoma	0.00112	0.00309	CcSEcCtD
Fosamprenavir—Asthenia—Levobunolol—glaucoma	0.00111	0.00308	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Betaxolol—glaucoma	0.00111	0.00308	CcSEcCtD
Fosamprenavir—Headache—Metipranolol—glaucoma	0.00111	0.00308	CcSEcCtD
Fosamprenavir—Pruritus—Levobunolol—glaucoma	0.0011	0.00304	CcSEcCtD
Fosamprenavir—Nervous system disorder—Bimatoprost—glaucoma	0.00109	0.00303	CcSEcCtD
Fosamprenavir—Dizziness—Carteolol—glaucoma	0.00109	0.00301	CcSEcCtD
Fosamprenavir—Skin disorder—Bimatoprost—glaucoma	0.00108	0.003	CcSEcCtD
Fosamprenavir—Diarrhoea—Carbachol—glaucoma	0.00108	0.00299	CcSEcCtD
Fosamprenavir—Flatulence—Pilocarpine—glaucoma	0.00108	0.00298	CcSEcCtD
Fosamprenavir—Dizziness—Diclofenamide—glaucoma	0.00107	0.00296	CcSEcCtD
Fosamprenavir—Asthenia—Methazolamide—glaucoma	0.00107	0.00296	CcSEcCtD
Fosamprenavir—Diarrhoea—Levobunolol—glaucoma	0.00106	0.00294	CcSEcCtD
Fosamprenavir—Angioedema—Dorzolamide—glaucoma	0.00106	0.00293	CcSEcCtD
Fosamprenavir—Nausea—Metipranolol—glaucoma	0.00105	0.00292	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00105	0.0029	CcSEcCtD
Fosamprenavir—Dizziness—Carbachol—glaucoma	0.00104	0.00289	CcSEcCtD
Fosamprenavir—Myalgia—Brimonidine—glaucoma	0.00103	0.00285	CcSEcCtD
Fosamprenavir—Headache—Carteolol—glaucoma	0.00103	0.00285	CcSEcCtD
Fosamprenavir—Vomiting—Diclofenamide—glaucoma	0.00103	0.00284	CcSEcCtD
Fosamprenavir—Dizziness—Levobunolol—glaucoma	0.00103	0.00284	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00102	0.00283	CcSEcCtD
Fosamprenavir—Pruritus—Latanoprost—glaucoma	0.00102	0.00282	CcSEcCtD
Fosamprenavir—Rash—Diclofenamide—glaucoma	0.00102	0.00282	CcSEcCtD
Fosamprenavir—Diarrhoea—Methazolamide—glaucoma	0.00102	0.00282	CcSEcCtD
Fosamprenavir—Headache—Diclofenamide—glaucoma	0.00101	0.0028	CcSEcCtD
Fosamprenavir—Vomiting—Carbachol—glaucoma	0.001	0.00278	CcSEcCtD
Fosamprenavir—Rash—Carbachol—glaucoma	0.000994	0.00275	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000993	0.00275	CcSEcCtD
Fosamprenavir—Dermatitis—Carbachol—glaucoma	0.000993	0.00275	CcSEcCtD
Fosamprenavir—Fatigue—Apraclonidine—glaucoma	0.000992	0.00275	CcSEcCtD
Fosamprenavir—Headache—Carbachol—glaucoma	0.000987	0.00274	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Betaxolol—glaucoma	0.000983	0.00272	CcSEcCtD
Fosamprenavir—Myalgia—Travoprost—glaucoma	0.00098	0.00271	CcSEcCtD
Fosamprenavir—Nausea—Carteolol—glaucoma	0.000975	0.0027	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000973	0.0027	CcSEcCtD
Fosamprenavir—Headache—Levobunolol—glaucoma	0.000972	0.00269	CcSEcCtD
Fosamprenavir—Nervous system disorder—Brimonidine—glaucoma	0.000969	0.00268	CcSEcCtD
Fosamprenavir—Myalgia—Brinzolamide—glaucoma	0.000967	0.00268	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000963	0.00267	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000961	0.00266	CcSEcCtD
Fosamprenavir—Skin disorder—Brimonidine—glaucoma	0.000959	0.00266	CcSEcCtD
Fosamprenavir—Nausea—Diclofenamide—glaucoma	0.000959	0.00266	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Betaxolol—glaucoma	0.000958	0.00265	CcSEcCtD
Fosamprenavir—Myocardial infarction—Betaxolol—glaucoma	0.000952	0.00264	CcSEcCtD
Fosamprenavir—Dizziness—Latanoprost—glaucoma	0.000952	0.00264	CcSEcCtD
Fosamprenavir—Vomiting—Methazolamide—glaucoma	0.000945	0.00262	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Apraclonidine—glaucoma	0.000941	0.00261	CcSEcCtD
Fosamprenavir—Rash—Methazolamide—glaucoma	0.000937	0.0026	CcSEcCtD
Fosamprenavir—Dermatitis—Methazolamide—glaucoma	0.000936	0.00259	CcSEcCtD
Fosamprenavir—Nausea—Carbachol—glaucoma	0.000936	0.00259	CcSEcCtD
Fosamprenavir—Headache—Methazolamide—glaucoma	0.000931	0.00258	CcSEcCtD
Fosamprenavir—Cardiac disorder—Clonidine—glaucoma	0.00093	0.00258	CcSEcCtD
Fosamprenavir—Myalgia—Pilocarpine—glaucoma	0.00093	0.00258	CcSEcCtD
Fosamprenavir—Nausea—Levobunolol—glaucoma	0.000922	0.00255	CcSEcCtD
Fosamprenavir—Nervous system disorder—Travoprost—glaucoma	0.000921	0.00255	CcSEcCtD
Fosamprenavir—Skin disorder—Travoprost—glaucoma	0.000912	0.00253	CcSEcCtD
Fosamprenavir—Abdominal pain—Apraclonidine—glaucoma	0.000909	0.00252	CcSEcCtD
Fosamprenavir—Nervous system disorder—Brinzolamide—glaucoma	0.000909	0.00252	CcSEcCtD
Fosamprenavir—Rash—Latanoprost—glaucoma	0.000907	0.00251	CcSEcCtD
Fosamprenavir—Dermatitis—Latanoprost—glaucoma	0.000906	0.00251	CcSEcCtD
Fosamprenavir—Headache—Latanoprost—glaucoma	0.000901	0.0025	CcSEcCtD
Fosamprenavir—Skin disorder—Brinzolamide—glaucoma	0.000901	0.0025	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Brimonidine—glaucoma	0.0009	0.00249	CcSEcCtD
Fosamprenavir—Anorexia—Dorzolamide—glaucoma	0.000899	0.00249	CcSEcCtD
Fosamprenavir—Decreased appetite—Acetazolamide—glaucoma	0.000894	0.00248	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000888	0.00246	CcSEcCtD
Fosamprenavir—Fatigue—Acetazolamide—glaucoma	0.000887	0.00246	CcSEcCtD
Fosamprenavir—Nausea—Methazolamide—glaucoma	0.000883	0.00245	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000859	0.00238	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Travoprost—glaucoma	0.000856	0.00237	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Brimonidine—glaucoma	0.000853	0.00236	CcSEcCtD
Fosamprenavir—Fatigue—Brimonidine—glaucoma	0.000851	0.00236	CcSEcCtD
Fosamprenavir—Anorexia—Pilocarpine—glaucoma	0.00085	0.00235	CcSEcCtD
Fosamprenavir—Hypersensitivity—Apraclonidine—glaucoma	0.000848	0.00235	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000845	0.00234	CcSEcCtD
Fosamprenavir—Asthenia—Apraclonidine—glaucoma	0.000825	0.00229	CcSEcCtD
Fosamprenavir—Decreased appetite—Dorzolamide—glaucoma	0.00082	0.00227	CcSEcCtD
Fosamprenavir—Pruritus—Apraclonidine—glaucoma	0.000814	0.00226	CcSEcCtD
Fosamprenavir—Body temperature increased—Acetazolamide—glaucoma	0.000813	0.00225	CcSEcCtD
Fosamprenavir—Fatigue—Dorzolamide—glaucoma	0.000813	0.00225	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000812	0.00225	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Travoprost—glaucoma	0.000811	0.00225	CcSEcCtD
Fosamprenavir—Fatigue—Travoprost—glaucoma	0.00081	0.00224	CcSEcCtD
Fosamprenavir—Cardiac disorder—Betaxolol—glaucoma	0.000809	0.00224	CcSEcCtD
Fosamprenavir—Decreased appetite—Brinzolamide—glaucoma	0.000806	0.00223	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Timolol—glaucoma	0.000803	0.00222	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000801	0.00222	CcSEcCtD
Fosamprenavir—Asthenia—Bimatoprost—glaucoma	0.0008	0.00222	CcSEcCtD
Fosamprenavir—Fatigue—Brinzolamide—glaucoma	0.000799	0.00222	CcSEcCtD
Fosamprenavir—Angioedema—Clonidine—glaucoma	0.000797	0.00221	CcSEcCtD
Fosamprenavir—Pruritus—Bimatoprost—glaucoma	0.000789	0.00219	CcSEcCtD
Fosamprenavir—Immune system disorder—Betaxolol—glaucoma	0.000788	0.00218	CcSEcCtD
Fosamprenavir—Diarrhoea—Apraclonidine—glaucoma	0.000787	0.00218	CcSEcCtD
Fosamprenavir—Decreased appetite—Pilocarpine—glaucoma	0.000775	0.00215	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dorzolamide—glaucoma	0.000771	0.00214	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000769	0.00213	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Travoprost—glaucoma	0.000768	0.00213	CcSEcCtD
Fosamprenavir—Dizziness—Apraclonidine—glaucoma	0.000761	0.00211	CcSEcCtD
Fosamprenavir—Malnutrition—Betaxolol—glaucoma	0.000759	0.0021	CcSEcCtD
Fosamprenavir—Abdominal pain—Dorzolamide—glaucoma	0.000746	0.00207	CcSEcCtD
Fosamprenavir—Body temperature increased—Dorzolamide—glaucoma	0.000746	0.00207	CcSEcCtD
Fosamprenavir—Abdominal pain—Travoprost—glaucoma	0.000742	0.00206	CcSEcCtD
Fosamprenavir—Asthenia—Acetazolamide—glaucoma	0.000738	0.00205	CcSEcCtD
Fosamprenavir—Dizziness—Bimatoprost—glaucoma	0.000738	0.00204	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000737	0.00204	CcSEcCtD
Fosamprenavir—Vomiting—Apraclonidine—glaucoma	0.000731	0.00203	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Pilocarpine—glaucoma	0.000729	0.00202	CcSEcCtD
Fosamprenavir—Hypersensitivity—Brimonidine—glaucoma	0.000728	0.00202	CcSEcCtD
Fosamprenavir—Dermatitis—Apraclonidine—glaucoma	0.000725	0.00201	CcSEcCtD
Fosamprenavir—Headache—Apraclonidine—glaucoma	0.000721	0.002	CcSEcCtD
Fosamprenavir—Asthenia—Brimonidine—glaucoma	0.000709	0.00196	CcSEcCtD
Fosamprenavir—Abdominal pain—Pilocarpine—glaucoma	0.000705	0.00195	CcSEcCtD
Fosamprenavir—Body temperature increased—Pilocarpine—glaucoma	0.000705	0.00195	CcSEcCtD
Fosamprenavir—Diarrhoea—Acetazolamide—glaucoma	0.000704	0.00195	CcSEcCtD
Fosamprenavir—Rash—Bimatoprost—glaucoma	0.000703	0.00195	CcSEcCtD
Fosamprenavir—Dermatitis—Bimatoprost—glaucoma	0.000703	0.00195	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Timolol—glaucoma	0.0007	0.00194	CcSEcCtD
Fosamprenavir—Pruritus—Brimonidine—glaucoma	0.000699	0.00194	CcSEcCtD
Fosamprenavir—Headache—Bimatoprost—glaucoma	0.000699	0.00194	CcSEcCtD
Fosamprenavir—Nervous system disorder—Clonidine—glaucoma	0.000698	0.00193	CcSEcCtD
Fosamprenavir—Hypersensitivity—Dorzolamide—glaucoma	0.000695	0.00193	CcSEcCtD
Fosamprenavir—Hypersensitivity—Travoprost—glaucoma	0.000692	0.00192	CcSEcCtD
Fosamprenavir—Skin disorder—Clonidine—glaucoma	0.000691	0.00192	CcSEcCtD
Fosamprenavir—Nausea—Apraclonidine—glaucoma	0.000683	0.00189	CcSEcCtD
Fosamprenavir—Hypersensitivity—Brinzolamide—glaucoma	0.000683	0.00189	CcSEcCtD
Fosamprenavir—Dizziness—Acetazolamide—glaucoma	0.00068	0.00189	CcSEcCtD
Fosamprenavir—Anorexia—Clonidine—glaucoma	0.000678	0.00188	CcSEcCtD
Fosamprenavir—Asthenia—Dorzolamide—glaucoma	0.000677	0.00188	CcSEcCtD
Fosamprenavir—Asthenia—Travoprost—glaucoma	0.000674	0.00187	CcSEcCtD
Fosamprenavir—Pruritus—Dorzolamide—glaucoma	0.000667	0.00185	CcSEcCtD
Fosamprenavir—Asthenia—Brinzolamide—glaucoma	0.000665	0.00184	CcSEcCtD
Fosamprenavir—Pruritus—Travoprost—glaucoma	0.000664	0.00184	CcSEcCtD
Fosamprenavir—Nausea—Bimatoprost—glaucoma	0.000662	0.00184	CcSEcCtD
Fosamprenavir—Cardiac disorder—Timolol—glaucoma	0.000661	0.00183	CcSEcCtD
Fosamprenavir—Hypersensitivity—Pilocarpine—glaucoma	0.000657	0.00182	CcSEcCtD
Fosamprenavir—Pruritus—Brinzolamide—glaucoma	0.000656	0.00182	CcSEcCtD
Fosamprenavir—Vomiting—Acetazolamide—glaucoma	0.000654	0.00181	CcSEcCtD
Fosamprenavir—Dizziness—Brimonidine—glaucoma	0.000653	0.00181	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Clonidine—glaucoma	0.000648	0.0018	CcSEcCtD
Fosamprenavir—Myalgia—Betaxolol—glaucoma	0.000646	0.00179	CcSEcCtD
Fosamprenavir—Diarrhoea—Dorzolamide—glaucoma	0.000645	0.00179	CcSEcCtD
Fosamprenavir—Headache—Acetazolamide—glaucoma	0.000645	0.00179	CcSEcCtD
Fosamprenavir—Immune system disorder—Timolol—glaucoma	0.000644	0.00178	CcSEcCtD
Fosamprenavir—Diarrhoea—Travoprost—glaucoma	0.000643	0.00178	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000642	0.00178	CcSEcCtD
Fosamprenavir—Asthenia—Pilocarpine—glaucoma	0.000639	0.00177	CcSEcCtD
Fosamprenavir—Diarrhoea—Brinzolamide—glaucoma	0.000634	0.00176	CcSEcCtD
Fosamprenavir—Pruritus—Pilocarpine—glaucoma	0.000631	0.00175	CcSEcCtD
Fosamprenavir—Dizziness—Dorzolamide—glaucoma	0.000624	0.00173	CcSEcCtD
Fosamprenavir—Rash—Brimonidine—glaucoma	0.000623	0.00173	CcSEcCtD
Fosamprenavir—Dermatitis—Brimonidine—glaucoma	0.000622	0.00172	CcSEcCtD
Fosamprenavir—Dizziness—Travoprost—glaucoma	0.000621	0.00172	CcSEcCtD
Fosamprenavir—Malnutrition—Timolol—glaucoma	0.00062	0.00172	CcSEcCtD
Fosamprenavir—Headache—Brimonidine—glaucoma	0.000619	0.00171	CcSEcCtD
Fosamprenavir—Decreased appetite—Clonidine—glaucoma	0.000619	0.00171	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Clonidine—glaucoma	0.000614	0.0017	CcSEcCtD
Fosamprenavir—Fatigue—Clonidine—glaucoma	0.000614	0.0017	CcSEcCtD
Fosamprenavir—Dizziness—Brinzolamide—glaucoma	0.000613	0.0017	CcSEcCtD
Fosamprenavir—Nausea—Acetazolamide—glaucoma	0.000611	0.00169	CcSEcCtD
Fosamprenavir—Diarrhoea—Pilocarpine—glaucoma	0.00061	0.00169	CcSEcCtD
Fosamprenavir—Nervous system disorder—Betaxolol—glaucoma	0.000608	0.00168	CcSEcCtD
Fosamprenavir—Skin disorder—Betaxolol—glaucoma	0.000602	0.00167	CcSEcCtD
Fosamprenavir—Vomiting—Dorzolamide—glaucoma	0.0006	0.00166	CcSEcCtD
Fosamprenavir—Rash—Dorzolamide—glaucoma	0.000595	0.00165	CcSEcCtD
Fosamprenavir—Dermatitis—Dorzolamide—glaucoma	0.000594	0.00165	CcSEcCtD
Fosamprenavir—Rash—Travoprost—glaucoma	0.000592	0.00164	CcSEcCtD
Fosamprenavir—Dermatitis—Travoprost—glaucoma	0.000592	0.00164	CcSEcCtD
Fosamprenavir—Headache—Dorzolamide—glaucoma	0.000591	0.00164	CcSEcCtD
Fosamprenavir—Anorexia—Betaxolol—glaucoma	0.000591	0.00164	CcSEcCtD
Fosamprenavir—Vomiting—Brinzolamide—glaucoma	0.00059	0.00163	CcSEcCtD
Fosamprenavir—Dizziness—Pilocarpine—glaucoma	0.000589	0.00163	CcSEcCtD
Fosamprenavir—Headache—Travoprost—glaucoma	0.000588	0.00163	CcSEcCtD
Fosamprenavir—Nausea—Brimonidine—glaucoma	0.000587	0.00163	CcSEcCtD
Fosamprenavir—Rash—Brinzolamide—glaucoma	0.000585	0.00162	CcSEcCtD
Fosamprenavir—Dermatitis—Brinzolamide—glaucoma	0.000584	0.00162	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Clonidine—glaucoma	0.000582	0.00161	CcSEcCtD
Fosamprenavir—Headache—Brinzolamide—glaucoma	0.000581	0.00161	CcSEcCtD
Fosamprenavir—Angioedema—Timolol—glaucoma	0.000567	0.00157	CcSEcCtD
Fosamprenavir—Vomiting—Pilocarpine—glaucoma	0.000567	0.00157	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000565	0.00156	CcSEcCtD
Fosamprenavir—Abdominal pain—Clonidine—glaucoma	0.000563	0.00156	CcSEcCtD
Fosamprenavir—Body temperature increased—Clonidine—glaucoma	0.000563	0.00156	CcSEcCtD
Fosamprenavir—Rash—Pilocarpine—glaucoma	0.000562	0.00156	CcSEcCtD
Fosamprenavir—Dermatitis—Pilocarpine—glaucoma	0.000561	0.00156	CcSEcCtD
Fosamprenavir—Nausea—Dorzolamide—glaucoma	0.00056	0.00155	CcSEcCtD
Fosamprenavir—Headache—Pilocarpine—glaucoma	0.000558	0.00155	CcSEcCtD
Fosamprenavir—Nausea—Travoprost—glaucoma	0.000558	0.00155	CcSEcCtD
Fosamprenavir—Nausea—Brinzolamide—glaucoma	0.000551	0.00153	CcSEcCtD
Fosamprenavir—Decreased appetite—Betaxolol—glaucoma	0.000539	0.00149	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Betaxolol—glaucoma	0.000535	0.00148	CcSEcCtD
Fosamprenavir—Fatigue—Betaxolol—glaucoma	0.000534	0.00148	CcSEcCtD
Fosamprenavir—Nausea—Pilocarpine—glaucoma	0.000529	0.00147	CcSEcCtD
Fosamprenavir—Myalgia—Timolol—glaucoma	0.000528	0.00146	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000524	0.00145	CcSEcCtD
Fosamprenavir—Hypersensitivity—Clonidine—glaucoma	0.000524	0.00145	CcSEcCtD
Fosamprenavir—Asthenia—Clonidine—glaucoma	0.000511	0.00141	CcSEcCtD
Fosamprenavir—Pruritus—Clonidine—glaucoma	0.000504	0.0014	CcSEcCtD
Fosamprenavir—Nervous system disorder—Timolol—glaucoma	0.000496	0.00138	CcSEcCtD
Fosamprenavir—Skin disorder—Timolol—glaucoma	0.000492	0.00136	CcSEcCtD
Fosamprenavir—Body temperature increased—Betaxolol—glaucoma	0.00049	0.00136	CcSEcCtD
Fosamprenavir—Diarrhoea—Clonidine—glaucoma	0.000487	0.00135	CcSEcCtD
Fosamprenavir—Anorexia—Timolol—glaucoma	0.000483	0.00134	CcSEcCtD
Fosamprenavir—Dizziness—Clonidine—glaucoma	0.000471	0.0013	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Timolol—glaucoma	0.000461	0.00128	CcSEcCtD
Fosamprenavir—Hypersensitivity—Betaxolol—glaucoma	0.000457	0.00126	CcSEcCtD
Fosamprenavir—Vomiting—Clonidine—glaucoma	0.000453	0.00125	CcSEcCtD
Fosamprenavir—Rash—Clonidine—glaucoma	0.000449	0.00124	CcSEcCtD
Fosamprenavir—Dermatitis—Clonidine—glaucoma	0.000448	0.00124	CcSEcCtD
Fosamprenavir—Headache—Clonidine—glaucoma	0.000446	0.00124	CcSEcCtD
Fosamprenavir—Asthenia—Betaxolol—glaucoma	0.000445	0.00123	CcSEcCtD
Fosamprenavir—Decreased appetite—Timolol—glaucoma	0.00044	0.00122	CcSEcCtD
Fosamprenavir—Pruritus—Betaxolol—glaucoma	0.000438	0.00121	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Timolol—glaucoma	0.000437	0.00121	CcSEcCtD
Fosamprenavir—Fatigue—Timolol—glaucoma	0.000436	0.00121	CcSEcCtD
Fosamprenavir—Diarrhoea—Betaxolol—glaucoma	0.000424	0.00117	CcSEcCtD
Fosamprenavir—Nausea—Clonidine—glaucoma	0.000423	0.00117	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Timolol—glaucoma	0.000414	0.00115	CcSEcCtD
Fosamprenavir—Dizziness—Betaxolol—glaucoma	0.00041	0.00114	CcSEcCtD
Fosamprenavir—Abdominal pain—Timolol—glaucoma	0.0004	0.00111	CcSEcCtD
Fosamprenavir—Body temperature increased—Timolol—glaucoma	0.0004	0.00111	CcSEcCtD
Fosamprenavir—Vomiting—Betaxolol—glaucoma	0.000394	0.00109	CcSEcCtD
Fosamprenavir—Rash—Betaxolol—glaucoma	0.000391	0.00108	CcSEcCtD
Fosamprenavir—Dermatitis—Betaxolol—glaucoma	0.00039	0.00108	CcSEcCtD
Fosamprenavir—Headache—Betaxolol—glaucoma	0.000388	0.00108	CcSEcCtD
Fosamprenavir—Hypersensitivity—Timolol—glaucoma	0.000373	0.00103	CcSEcCtD
Fosamprenavir—Nausea—Betaxolol—glaucoma	0.000368	0.00102	CcSEcCtD
Fosamprenavir—Asthenia—Timolol—glaucoma	0.000363	0.00101	CcSEcCtD
Fosamprenavir—Pruritus—Timolol—glaucoma	0.000358	0.000992	CcSEcCtD
Fosamprenavir—Diarrhoea—Timolol—glaucoma	0.000346	0.00096	CcSEcCtD
Fosamprenavir—Dizziness—Timolol—glaucoma	0.000335	0.000928	CcSEcCtD
Fosamprenavir—Vomiting—Timolol—glaucoma	0.000322	0.000892	CcSEcCtD
Fosamprenavir—Rash—Timolol—glaucoma	0.000319	0.000884	CcSEcCtD
Fosamprenavir—Dermatitis—Timolol—glaucoma	0.000319	0.000884	CcSEcCtD
Fosamprenavir—Headache—Timolol—glaucoma	0.000317	0.000879	CcSEcCtD
Fosamprenavir—Nausea—Timolol—glaucoma	0.000301	0.000833	CcSEcCtD
